Jupiter Wellness, Inc.: Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns
JUPITER, FL / ACCESSWIRE / October 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced
United States Kostenloser Wertpapierhandel Brian John Jupiter Wellness Inc Jupiter Wellness Private Securities Litigation Reform Act
Source: finanznachrichten.de